PATENT CLAIM ANALYSIS

Application Number: 16204559
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "464000"]

Abstract:
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects.

Claim (Index 52):
The pharmaceutical dosage form of  claim 50 , wherein the capsule is a soft gelatin capsule.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.44262
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13143498', '12529674', '14240380', '09823202', '13973456']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6956369922143896
- 35 USC 102 Novelty (BERT): 0.5166484367747668
- Combined Prediction Score: 0.6777381366704274
- Mean Citation Score: 188.15742
- Max Citation Score: 236.81842000000003
- Similarity Product: 130.43187059977532

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test